QLGN
$1.05
Qualigen Therapeutics
$.05
5.00%
QLGN
Earnings Whisper ®
N/A
3rd Quarter December 2021
Consensus:  $0.00
Revenue:  $1.50 Mil
Monday
Feb 14
After the close
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when QLGN reports earnings?
Beat
Meet
Miss

Where is QLGN's stock price going from here?
Up
Flat
Down
Stock chart of QLGN
Analysts
Summary of analysts' recommendations for QLGN
Score
Grade
Pivots
Resistance
$1.13
$1.10
$1.07

$1.04

Support
$1.01
$0.98
$0.95
Tweet
Growth
Description
Qualigen Therapeutics Inc. is a biotechnology company. It is focused on developing products for the treatment and testing of cancer and infectious diseases. The company's product pipeline consist AS1411 and Gold Nanoparticle ALAN, RAS-F3 and STARS(TM) blood cleansing system, which are in clinical stage. Qualigen Therapeutics Inc., formerly known as Ritter Pharmaceuticals Inc., is based in CA, United States.